To predict the risk of malignancy in ovarian tumors, the multi-class risk prediction Assessment of Different NEoplasias in the adneXa (ADNEX) model of the International Ovarian Tumor Analysis group is used internationally.
This study aimed to perform an external validation of this model in a real-world clinical setting in the Netherlands.
